Molecular evolution of GII-4 norovirus strains

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Zakikhany, Katherina ^a,b   Allen, David J ^a   Brown, David ^a   Iturriza Gómara, Miren ^a,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P2;

AMINO ACID SUBSTITUTION; ARTICLE; BIODIVERSITY; CONTROLLED STUDY; GENE CLUSTER; GENETIC SCREENING; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN DOMAIN; PYROSEQUENCING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SURFACE PROPERTY; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIGENS, VIRAL; CAPSID PROTEINS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HUMANS; NOROVIRUS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84864858384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041625     Document Type: Article

References (31)

1. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, et al. ((2011)) Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut (2012) 61(1):: 69--77.
2. Hutson AM, Atmar RL, Estes MK, ((2004)) Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol 12:: 279--287.
3. Harris JP, Edmunds WJ, Pebody R, Brown DW, Lopman BA, ((2008)) Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis 14:: 1546--1552.
4. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, et al. ((2006)) Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect 12:: 69--74.
5. Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, et al. ((2010)) Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J Clin Virol 49:: 219--222.
6. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, et al. ((2006)) Norovirus classification and proposed strain nomenclature. Virology 346:: 312--323.
7. Teunis PF, Moe CL, Liu P, Miller SE, Lindesmith L, et al. ((2008)) Norwalk virus: how infectious is it? J Med Virol 80:: 1468--1476.
8. Matsui SM, Greenberg HB, ((2000)) Immunity to Calicivirus Infection. J Infect Dis 181:: S331--S335.
9. Johnson PC, Mathewson JJ, DuPont HL, Greenberg HB, ((1990)) Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 161:: 18--21.
10. Koopman JS, Eckert EA, Greenberg HB, Strohm BC, Isaacson RE, et al. ((1982)) Norwalk virus enteric illness acquired by swimming exposure. Am J Epidemiology 115:: 173--177.
11. Tan M, Jiang X, ((2005)) Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 13:: 285--293.
12. Tan M, Jiang X, ((2008)) Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent. J Infect Dis 198:: 940--941.
13. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS, ((2010)) Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol 8:: 231--241.
14. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, et al. ((2008)) Mechanisms of GII.4 Norovirus Persistence in Human Populations. PLoS Med 5:: e31.
15. Allen DJ, Gray JJ, Gallimore CI, Xerry J, Iturriza Gomara M, ((2008)) Analysis of Amino Acid Variation in the P2 Domain of Norovirus VP1 Protein Reveals Putative Variant-Specific Epitopes. PLoS One 3:: 1--9.
16. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, et al. ((2007)) Epochal Evolution of GGII.4 Norovirus Capsid Proteins from 1995 to 2006. J Virol 81:: 9932--9941.
17. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, et al. ((2004)) Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363:: 682--688.
18. Allen DJ, Noad R, Samuel D, Gray JJ, Roy P, et al. ((2009)) Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virology Journal 6:: 150.
19. Xerry J, Gallimore CI, Iturriza Gomara M, Allen DJ, Gray JJ, ((2008)) Transmission Events Within Outbreaks of Gastroenteritis Determined Through the Analysis of Nucleotide Sequences of the P2 Domain of Genogroup II Noroviruses J Clin Microbiol. 46:: 947--953.
20. Hall TA, ((1999)) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:: 95--98.
21. Guex N, Peitsch MC, ((1997)) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:: 2714--2723.
22. Cao S, Lou Z, Tan M, Chen Y, Liu Y, et al. ((2007)) Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus. J Virol. 81(11):: 5949--57.
23. Lindesmith LC, Donaldson EF, Baric RS, ((2011)) Norovirus GII.4 Strain Antigenic Variation. J Virol 85:: 231--242.
24. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, et al. ((2009)) Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 83:: 11890--11901.
25. Kroneman A, Vennema H, van Duijnhoven YT, Duizer E, Koopmans M, ((2004)) High number of norovirus outbreaks associated with a GGII.4 variant in the Netherlands and elsewhere: does this herald a worldwide increase? EuroSurveillance 8.
26. Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA, ((2006)) Emergence of a New Norovirus Genotype II.4 Variant Associated with Global Outbreaks of Gastroenteritis. J Clin Microbiol 44:: 327--333.
27. Yen C, Wikswo ME, Lopman BA, Vinje J, Parashar UD, et al. ((2011)) Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis 53:: 568--571.
28. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, et al. ((2011)) Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 17:: 1389--1395.
29. Debbink K, Donaldson EF, Lindesmith LC, Baric RS, ((2012)) Genetic Mapping of a Highly Variable Norovirus GII.4 Blockade Epitope: Potential Role in Escape from Human Herd Immunity. J Virol 86:: 1214--1226.
30. Siebenga JJ, Lemey P, Kosakovsky Pond SL, Rambaut A, Vennema H, et al. ((2010)) Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog 6:: e1000884.
31. Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, et al. ((2011)) Structural Analysis of Histo-Blood Group Antigen Binding Specificity in a Norovirus GII.4 Epidemic Variant: Implications for Epochal Evolution. J Virol 85:: 8635--8645.